Innovative Diagnostic Peptide‐Based Technologies for Cancer Diagnosis: Focus on EGFR‐Targeting Peptides-Reference-Cited by-同舟云学术

Innovative Diagnostic Peptide‐Based Technologies for Cancer Diagnosis: Focus on EGFR‐Targeting Peptides

Published:2022-12-05 Issue:3 Volume:18 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Ahmadi Mohammad¹²³,Ahmadyousefi Yaghoub²³,Salimi Zahra⁴,Mirzaei Rasoul⁵⁶,Najafi Rezvan²³,Amirheidari Bagher⁷⁸,Rahbarizadeh Fatemeh⁹,Kheshti Javad⁴,Safari Armin⁴,Soleimani Meysam⁴^ORCID

Affiliation:

1. Department of Biotechnology School of Advanced Technologies in Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

2. Department of Medical Biotechnology School of Advanced Medical Sciences and Technologies Hamadan University of Medical Sciences Hamadan Iran

3. Research Center for Molecular Medicine School of Medicine Hamadan University of Medical Sciences Hamadan Iran

4. Department of Pharmaceutical Biotechnology School of Pharmacy Hamadan University of Medical Sciences Hamadan Iran

5. Venom and Biotherapeutics Molecules Lab Medical Biotechnology Department Biotechnology Research Center Pasteur Institute of Iran Tehran Iran

6. Department of Microbiology School of Medicine Hamadan University of Medical Sciences Hamadan Iran

7. Department of Pharmaceutical Biotechnology Faculty of Pharmacy Kerman University of Medical Sciences Kerman Iran

8. Extremophile and Productive Microorganisms Research Center Kerman University of Medical Sciences Kerman Iran

9. Department of Medical Biotechnology Faculty of Medical Sciences Tarbiat Modares University Tehran Iran

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200506

Reference128 articles.

2. Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer

4. The Potential Use of Peptides in Cancer Treatment

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics;International Journal of Molecular Sciences;2024-08-05

2. Novel engineered HER2 specific recombinant protein nanocages for targeted drug delivery;Molecular Biology Reports;2024-06-21

3. Advancements in ovarian cancer immunodiagnostics and therapeutics via phage display technology;Frontiers in Immunology;2024-05-28

4. 20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11